In addition, downregulation of circETS1 promoted SLE activity and inhibited Treg cell differentiation through miR-1205/FoxP3 molecular axis, which may be a novel target for SLE treatment (125). The gene discussed is FOXP3; the disease is systemic lupus erythematosus.